GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OTCPK:VACBF) » Definitions » Interest Expense (Positive)

VACBF (Nykode Therapeutics AS) Interest Expense (Positive)


View and export this data going back to 2020. Start your Free Trial

What is Nykode Therapeutics AS Interest Expense (Positive)?

Interest Expense (Positive) only applies to insurance companies.


Nykode Therapeutics AS Business Description

Traded in Other Exchanges
Address
Gaustadalleen 21, Oslo Research Park, Oslo, NOR, 0349
Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate therapeutics to treat cancers with a high unmet medical need.